| Similar Articles |
|---|
 |
BusinessWeek
January 14, 2010
Rob Waters |
Amgen: Strengthening Bones, Weakening Cancer? Regulators may soon approve an Amgen drug, denosumab, for osteoporosis, but the payoff could be in oncology.   |
Science News
August 3, 2002
Janet Raloff |
Surprise! Obesity (and inactivity) can spur cancers Some 60 percent of U.S. adults say they're worried at the prospect of developing cancer, yet only 6 percent recognize that being overweight is a leading predisposing factor. |
The Motley Fool
December 14, 2010
Brian Orelli |
An Ounce of Prevention, a Pound of Blockbuster Sales Amgen's Xgeva recently gained Food and Drug Administration approval to treat cancer patients that have bone metastasis. |
The Motley Fool
June 6, 2011
Luke Timmerman |
Exelixis Zeroes In on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients Is Exelixis' risky bet about to pay off? |
Managed Care
March 2007
Martin Sipkoff |
Managing Cancer Treatment Begins Before Diagnosis Health plans are increasingly involved in promoting the lifestyle changes that help their members avoid cancer, and are increasingly involved in clinical trials if prevention fails. |
Science News
January 25, 2003
Kendall Morgan |
Curbing Cancer? Low-Fat Diet During Adolescence Cuts Hormones, Possibly Breast Cancer Risk Cutting back on cheeseburgers and French fries could spare girls more than extra pounds. A low-fat diet also reduces young girls' sex hormone concentrations, a new study finds. The adolescent drop in hormones that are known to spur breast cancer in adults might stave off the disease later in life. |
BusinessWeek
May 23, 2005
Catherine Arnst |
If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer. |
The Motley Fool
June 17, 2010
Luke Timmerman |
Oncothyreon's Cancer Vaccine Back in the Saddle as Merck KGaA Re-Starts Clinical Trials The German-based Merck got clearance from the FDA and local ethics review boards to resume two of three large pivotal trials. |
Salon.com
November 10, 2000
Laurie Tarkan |
The business of breast cancer Big medicine is making big bucks on the disease, but we're still far from a cure... |
HHMI Bulletin
Nov 2010 |
Fusion genes that drive solid tumors are a new target for cancer therapies The success of Gleevec and related drugs has inspired researchers to step up their hunt for the molecular defects underlying other cancers. |
Chemistry World
September 7, 2015 |
Cancer Drugs Fund axes 23 treatments The Cancer Drugs Fund, which covers the cost of some cancer treatments that are not currently available on the National Health Service, has cut 23 treatments -- involving 16 drugs. |
Scientific American
March 2009
Elaine Schattner |
A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment |
BusinessWeek
October 17, 2005
Catherine Arnst |
Breast-Cancer Screening: How to Choose Women have varying risk factors for breast cancer and face more test options. Here are some key considerations for making a suitable choice. |
Health
March 2008
Dorothy Foltz-Gray |
How Weighing Too Much Hurts You Being overweight can up your risk for certain diseases. |
BusinessWeek
July 3, 2006
Catherine Arnst |
A Ton Of Prevention The pros and cons of two drugs that may halve your risk of breast cancer. |
American Family Physician
February 1, 2001
Thomas J. Gates |
Screening for Cancer: Evaluating the Evidence This article reviews the kind of evidence required to justify screening tests for cancer, with the goal of guiding family physicians through current and future screening controversies... |
American Family Physician
March 15, 2004 |
Breast Cancer Risk Related to Type of Hormone Therapy Although several studies have demonstrated an increased risk of breast cancer in postmenopausal women taking oral hormone therapy, the risk related to each of the various forms of therapy is less clear. |
American Family Physician
February 15, 2005
Sunga et al. |
Care of Cancer Survivors Cancer survivors are at increased risk for recurrence of their original malignancy. Surveillance following curative cancer treatment generally includes interval history and physical examinations every six months for five years. |
Science News
June 8, 2002
Janet Raloff |
Pudgy? Here's a Small Benefit For those women whose proportions fall outside the fatfree ideal, here's one consolation: Your outsized physique appears to put you at decreased risk of developing ovarian cancer (a somewhat rare cancer). |
The Motley Fool
August 14, 2009
Brian Orelli |
Amgen Close to Scoring Big Amgen gets good-enough results from a FDA panel. |
Salon.com
September 20, 2000
Cathy Young |
Medical gender wars First came the whining feminists. Next, the inevitable male backlash. Health research has become a casualty of the battle between the sexes. |
The Motley Fool
September 28, 2010
Brian Orelli |
Pfizer's Sutent Fails. Again! No surprise here. |
American Family Physician
March 15, 2001 |
Cancer Screening Guidelines Faced with the broad, and sometimes conflicting, range of recommendations for cancer screening, family physicians must determine the most reasonable and up-to-date method of screening... |
Salon.com
July 14, 2000
Arthur Allen |
The cancer study bombshell that wasn't Were the New York Times and the Washington Post writing about the same New England Journal of Medicine article? |
Nutra Solutions
July 1, 2005 |
Soy Claims Count Regular consumption of soy protein-containing foods and beverages may reduce the risk of breast cancer in women by as much as 22%, reports a study published in The International Journal of Cancer Prevention. |
Managed Care
January 2005
Sharon Baker |
Breast Cancer Screening: Some Plans Do Better Than Others Some of the nation's best health plans are coming up with creative ways to encourage women to get mammograms. |
Chemistry World
January 21, 2011
Jennifer Newton |
Early lung cancer diagnosis Patients with lung cancer have elevated levels of a specific protein in their blood that could be used as a biomarker for the disease, say scientists from South Korea. |
Nurse Practitioner
October 2009
Wallace et al. |
Shedding light on prostate cancer This article will discuss the risk factors, signs and symptoms, diagnosis of prostate cancer, and disease staging and grading, as well as necessary lab and diagnostic tests, treatment options and patient education. |
| AskMen.com |
Good Health Care News New advice from the American Cancer Society puts a sharper focus on the risks of prostate cancer screening, emphasizing that annual testing can lead to unnecessary biopsies and treatments that do more harm than good. |
American Family Physician
June 15, 2005
Laura Coughlin |
Quantum Sufficit - Just Enough Do you ever think of new medical breakthroughs as "space-age medicine"?... Everyone knows that being overweight has health risks... An electronic nose has long been used in the food, wine, and perfume industries... etc. |
AskMen.com
September 30, 2000
Joshua Levine |
Male Breast Cancer Breast cancer is traditionally thought of as a female-related problem. Men, however, are as susceptible to the disease as women are. In many ways, the disease appears similarly in both sexes... |
HHMI Bulletin
May 2011
Dan Ferber |
Revealing the Biological Complexity of Bones Bones are the body's framework and support, our strongest tissues. Unlike the scaffold of a building, however, bones are anything but inert. They pulse with life and their maintenance requires a surprisingly delicate balancing act. |
American Family Physician
August 1, 2000
Lecia M. Apantaku |
Breast Cancer Diagnosis and Screening Statistics on breast cancer risk, symptoms and recommended tests. |
Nurse Practitioner
November 2010
Dreadin & Mancuso |
Diagnostic breast evaluation: When to refer and what the results really mean Diagnostic breast imaging is an important tool in evaluating abnormal physical examination findings and assessing incomplete screening mammographic results. |
American Family Physician
March 15, 2007
Mark H. Ebell |
Point-of-Care Guides: Estimating 10-Year Mortality Risks Clinical Question: What is a patient's risk of dying from vascular disease, cancer, infection, an accident, or any cause within the next 10 years?... Evidence Summary... Applying the Evidence... etc. |
American Family Physician
December 15, 2002
Randhawa & Fink |
Screening for Breast Cancer A case study and question-and-answer group on screening for breast cancer, based on the recommendations of the current U.S. Preventive Services Task Force |
The Motley Fool
March 13, 2009
Brian Orelli |
Pfizer Finally Gets a Hit! Positive results on Pfizer's cancer drug Sutent come earlier than expected. |
Salon.com
April 28, 2000
Dawn MacKeen |
A disease fueled by testosterone When a politician announces he has prostate cancer, what does it mean? |
Salon.com
October 12, 1999
Damien Cave |
Male mastectomy Not many men get breast cancer, but too few are aware of the risk. |
ifeminists
October 15, 2002
Sacks & Thompson |
When Men's Health Doesn't Count Congress is sending a message to American men: men's health doesn't count. |
Nurse Practitioner
August 2010
Virginia Sun |
Update on Pancreatic Cancer Treatment Pancreatic cancer is the 10th leading type of all new cancer cases and the fourth leading type of cancer death that affects both men and women. |
American Family Physician
June 1, 2001
James M. Lyznicki |
Obesity: Assessment and Management in Primary Care Obesity is a complex, multifactorial condition in which excess body fat may put a person at health risk. National data indicate that the prevalence of obesity in the United States is increasing in children and adults... |
AskMen.com
Jacob Franek |
Men's Health Screening Guide Use this men's health screening schedule to stay in top health. |
American Journal of Nursing
September 2009
Lockwood-Rayermann et al. |
Original Research: Women's Awareness of Ovarian Cancer Risks and Symptoms Objective: To assess how well informed women ages 40 and older are of ovarian cancer symptoms and risk factors. |
The Motley Fool
April 28, 2009
Brian Orelli |
Headline? Bad! Unexpected? No! For a company that only has one drug on the market, stopping a failing phase 3 clinical trial that's designed to expand the market of that drug is usually a major blow. But Onyx Pharmaceuticals was able to shrug it off. |
ifeminists
October 29, 2002
Rondi Adamson |
Re-Evaluating the Risk of Breast Cancer As breast cancer became a poster disease for feminism in the 1980s, the attention it began to receive took on unreasonable proportions. In short, the intensity of funding, publicity and research around breast cancer is not based on need. It is based on politics. |
The Motley Fool
May 4, 2009
Robert Steyer |
Beyond Provenge -- The Next Hot Cancer Drug? The search for prostate cancer treatments is filled with prospects and littered with failures. Which companies have the best chance of success? |
BusinessWeek
October 17, 2005 |
The Laughter Cure Monique Spencer couldn't find what she wanted in books about breast cancer. So she wrote her own - and made it funny. |
Reason
May 2001
Cathy Young |
False Diagnosis When it comes to gender, doctors don't play favorites... |
American Family Physician
February 15, 2005 |
Health Care After Cancer Treatment An informative patient hand-out on follow-up cancer care. |
